BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 33831476)

  • 21. Extracellular matrix remodeling and cardiac fibrosis.
    Li L; Zhao Q; Kong W
    Matrix Biol; 2018 Aug; 68-69():490-506. PubMed ID: 29371055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K
    She G; Ren YJ; Wang Y; Hou MC; Wang HF; Gou W; Lai BC; Lei T; Du XJ; Deng XL
    J Am Heart Assoc; 2019 Jan; 8(1):e010418. PubMed ID: 30563389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPRC5B promotes collagen production in myofibroblasts.
    Takizawa N; Hironaka T; Mae K; Ueno T; Horii Y; Nagasaka A; Nakaya M
    Biochem Biophys Res Commun; 2021 Jul; 561():180-186. PubMed ID: 34023784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanical regulation of myofibroblast phenoconversion and collagen contraction.
    Hinz B; McCulloch CA; Coelho NM
    Exp Cell Res; 2019 Jun; 379(1):119-128. PubMed ID: 30910400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microcurrent-Mediated Modulation of Myofibroblasts for Cardiac Repair and Regeneration.
    Bachamanda Somesh D; Jürchott K; Giesel T; Töllner T; Prehn A; Richters JP; Kosevic D; Eduardo Rame J; Göttel P; Müller J
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis.
    Rodriguez P; Sassi Y; Troncone L; Benard L; Ishikawa K; Gordon RE; Lamas S; Laborda J; Hajjar RJ; Lebeche D
    Eur Heart J; 2019 Mar; 40(12):967-978. PubMed ID: 29668883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis.
    Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G
    Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulators of cardiac fibroblast cell state.
    Bretherton R; Bugg D; Olszewski E; Davis J
    Matrix Biol; 2020 Sep; 91-92():117-135. PubMed ID: 32416242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure.
    Li Y; Song D; Mao L; Abraham DM; Bursac N
    Biomaterials; 2020 Apr; 236():119824. PubMed ID: 32028169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of human cardiac fibroblasts with the protein arginine deiminase inhibitor BB-Cl-amidine activates the Nrf2/HO-1 signaling pathway.
    Stachowicz A; Sadiq A; Walker B; Sundararaman N; Fert-Bober J
    Biomed Pharmacother; 2023 Nov; 167():115443. PubMed ID: 37703660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
    Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
    Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
    Weber KT; Sun Y; Bhattacharya SK; Ahokas RA; Gerling IC
    Nat Rev Cardiol; 2013 Jan; 10(1):15-26. PubMed ID: 23207731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifibrotic response of cardiac fibroblasts in hypertensive hearts through enhanced TIMP-1 expression by basic fibroblast growth factor.
    Kinoshita T; Ishikawa Y; Arita M; Akishima-Fukasawa Y; Fujita K; Inomata N; Suzuki T; Namiki A; Mikami T; Ikeda T; Yamazaki J; Ishii T; Akasaka Y
    Cardiovasc Pathol; 2014; 23(2):92-100. PubMed ID: 24322055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BNIP3L promotes cardiac fibrosis in cardiac fibroblasts through [Ca
    Liu W; Wang X; Mei Z; Gong J; Huang L; Gao X; Zhao Y; Ma J; Qian L
    Sci Rep; 2017 May; 7(1):1906. PubMed ID: 28507335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
    Li CJ; Lv L; Li H; Yu DM
    Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cadherin-11 and cardiac fibrosis: A common target for a common pathology.
    Riley LA; Merryman WD
    Cell Signal; 2021 Feb; 78():109876. PubMed ID: 33285242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling cardiac fibrosis through fibroblast state space modulation.
    Reichardt IM; Robeson KZ; Regnier M; Davis J
    Cell Signal; 2021 Mar; 79():109888. PubMed ID: 33340659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.
    Dobaczewski M; de Haan JJ; Frangogiannis NG
    J Cardiovasc Transl Res; 2012 Dec; 5(6):837-47. PubMed ID: 22956156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host responses in tissue repair and fibrosis.
    Duffield JS; Lupher M; Thannickal VJ; Wynn TA
    Annu Rev Pathol; 2013 Jan; 8():241-76. PubMed ID: 23092186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.